ASEP Medical Holdings Inc.
ASEP Medical Holdings Inc. has invested in two development stage companies, ABT Innovations Inc. (ABT) and Sepset Biosciences Inc. (Sepset). This consolidation is pursuing the commercialization of proprietary Peptide Technologies by ABT for the treatment of a broad range of infectious diseases, and a novel diagnostic kit developed by Sepset for predicting the early onset of severe sepsis and related organ failure.
ASEP Medical Holdings Inc. (ASEP)
Le 10 mai/May 2022
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.